Fudan Zhangjiang: The first subject has been enrolled in the Phase I clinical trial of intravenous FZ-P001 sodium for visualizing malignant lesions in ovarian cancer surgery.

Fudan Zhangjiang announcement: The company's injection FZ-P001 sodium, developed for visualizing malignant lesions in ovarian cancer surgery, has successfully completed the first subject's enrollment in Phase I clinical trial recently.